Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel treatment options for cancer covered in recent patent literature

Nov. 30, 2007

Cyclacel presents an update on clinical development programs

Nov. 29, 2007

New agents with potential in the treatment of cancer disclosed in recent patent literature

Nov. 29, 2007

E.U. approves Tasigna for Ph+ CML patients with poor response to current therapy

Nov. 28, 2007

Kinex initiates phase I clinical trial of KX2-391 for advanced solid tumors and lymphoma

Nov. 28, 2007

Cleveland BioLabs initiates phase II trial of Curaxin for advanced renal cell carcinoma

Nov. 28, 2007

EMEA accepts for technical review MAA submission by Introgen for Advexin

Nov. 28, 2007

VioQuest initiates phase IIa study of Lenocta for the treatment of solid tumors

Nov. 27, 2007

Merck & Co. files marketing authorization application with EMEA for vorinostat

Nov. 27, 2007

European Commission approves Wyeth Pharmaceuticals' Torisel for renal cell carcinoma

Nov. 27, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...